Beo Therapeutics seek to partner with companies from the pharmaceutical, medical food or food-supplement sector with an interest in urate lowering therapies. Beo Therapeutics delivers products with pre-clinical and clinical proof of concept for commercialisation as food-supplement, medical food or (non-) prescription drug.
Supported by Business Angels Switzerland
BAS supports young companies and invests to take a minority stake in the companies. Startups can profit from the active role that BAS members take in the company, like unpaid consultants.